Lmr Partners LLP Catalyst Biosciences, Inc. Transaction History

Lmr Partners LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 14, 2020	SELL	$4.52 - $7.91 $57,756 - $101,073	-12,778 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.08 - $10.6 $90,468 - $135,446	12,778 New	12,778 $94,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.